US 6667313
8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators
expired A61PA61P13/08A61P15/00
Quick answer
US patent 6667313 (8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Dec 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P13/08, A61P15/00, A61P15/08, A61P17/00